UPDATE - Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV - November 2021
What’s New
Key updates to the guidelines include the following:
Appendix B: Panel Roster and Financial Disclosures
• Updated member conflict of interest information for 2021-2022
• Updated roster to include 22 new members, 6 new Section Group Leads and 1 new Leadership member.
Immunizations
•The immunization section has been updated to reflect the recommendation that all people with HIV should receive the COVID-19 vaccine regardless of their CD4 T lymphocyte count or HIV viral load.
• People with advanced or untreated HIV who received a 2-dose series with one of the mRNA COVID-19 vaccines should receive a third dose of that vaccine at least 28 days after the second dose.
•The zoster vaccine is now recommended for people with HIV age 18 years old and older in alignment with Advisory Committee on Immunization Practices (ACIP) recommendations